Report Categories
View AllRecent Articles
View All
Abacus Global ABX misses Q1 earnings estimates by 48 shares decline 32 amid investor concerns
Finward Bancorp FNWD Stock Month Start Institutional Selling 20260415
Theriva Biologics TOVX Comprehensive Review Theriva Biologics posts 346 EPS beat no revenue
Gabelli GUT Sector Impact
BWNB Babcock 2026 posts far stronger Q4 2025 EPS than expected yet shares dip marginally today
PGR Progressive delivers Q1 2026 earnings beat and 163 percent revenue growth shares edge higher
EV CA Muni CEV Stock Why It Could Rebound Near Highs 20260420
Elon Musks Lawsuit Against OpenAI CEO Sam Altman Dismissed by Jury
Northeast Bank NBN Q1 2026 Results Top Views on Strong Revenue
GSTAT President Orders New Listing Mechanism for All Benches Nationwide
Amplitech AMPGR Up 15000 Is There More Room to Run 20260519
Cineverse CNVS Reports Strong Q1 2026 Revenue NA EPS Beats
Hennessy HVII Flat at 1042 Consolidation Continues 20260517
Jeff Bezos Proposes Tax Overhaul Aimed at LowerIncome Americans
SpaceX IPO Faces Caution as Market Analysts Flag Key Risks
Nu Holdings Posts Record Q1 2026 Revenue Above 5 Billion Net Income Surges 41
Sandisk CTO AI Race Shifts Focus from Compute to Memory
Former Prince Andrew Faces Expanded Police Investigation Potential Financial Repercussions
Federal Reserve Monetary Policy Stance Under Scrutiny Amid Inflation and Growth Concerns
Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment
FINV Q1 2026 Earnings Profitability Highlighted as Stock Declines Amid Uncertain Macro Outlook
CWK Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Resilience
PSEC Q1 2026 Earnings Earnings Miss Estimates Stock Gains Marginally
RUM Q1 2026 Earnings WiderThanExpected Loss Fails to Deter Investors
MESO Q1 2026 Earnings Slightly Wider Loss in PreRevenue Quarter Stock Advances
GreenTree Hospitality GHG Retreats Near Support Trading at 112
FS Bancorp Inc FSBW Gains 157 as Stock Approaches Key Resistance Level
Incannex Healthcare IXHL Slips 455 as Biotech Selling Pressure Persists
Akebia Therapeutics AKBA Holds Steady at 102 as Stock Consolidates Near Key Support
MarisTech Ltd Warrants MTEKW Hover at 016 Support and Resistance Define NearTerm Outlook